Anti-Kickback Statute (AKS): How Does It Affect Your Practice?

About this Live Interactive Webinar

The federal Anti-Kickback Statute (AKS) is a criminal statute known for its wide-ranging effects on business relationships in the health care, pharmaceutical, and medical device sectors. These regulations were finalized and published in the Federal Register in December 2020. Designed to keep pace with the transition from volume-based healthcare to a value-based system that reimburses based on the quality of patient care provided. 

No CE will be offered with this webinar. 

Learning Objectives

At the end of the presentation, the participant will be able to:

1. Evaluate allowed reimbursements. 2. Identify how this anti-corruption statute protects federal health care programs from the influence of money on referrals. 3. Guard against overutlization, increased costs and poor quality services

Presenter

Stefanie Doebler, JD, 
Covington & Burling, LLP

Stefanie Doebler is co-chair of the firm's Health Care Practice Group, and a member of the Food, Drug, and Device Practice Group. Her practice focuses on health care compliance matters for pharmaceutical, biotech, and medical device clients. She provides advice related to advertising and promotion, fraud and abuse, transparency requirements, state law compliance and reporting regulations, interactions with health care professionals, Medicaid price reporting, and other aspects of federal and state regulation of pharmaceuticals, biologics, and medical devices. Ms. Doebler also advises on the development and implementation of health care compliance programs.